Trial Profile
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Acoustic neuroma; Neurofibromatosis 2
- Focus Therapeutic Use
- 08 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.